FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Free Newsletter

About | View Sample | Privacy

CRO automates test item control

Tools

WuXi AppTec has purchased the Provantis preclinical software from Instem for use in a newly constructed, 314,000-square-foot toxicology facility in Suzhou, China. The contract research organization, which purchased modules for its general toxicology, clinical pathology, pathology and formulations departments, will integrate the modules and use them to aid in test item control.

The software targets researchers engaged in non-clinical evaluation studies, says an announcement. It helps users orchestrate the functions of preclinical drug safety assessment, in both GLP and non-GLP environments. The software is also compliant with 21 CFR Part 11.

Another Provantis customer is Merck Serono, which selected Provantis 8 for its R&D lab in Ivrea, Italy, and a facility in recently started a global Toxicology Data Management System. The drug maker selected Provantis 8 for its Research & Development laboratory in Ivrea, Italy and will also be upgrading to Provantis 8 at its facility in Darmstadt, Germany

- here's the WuXi announcement
- see the Merck Serono release

Related Article:
China's WuXi buys Apptec for $151M


SHARE
WITH:
Email Twitter Facebook LinkedIn StumbleUpon
Get Your FREE FierceBiotechIT Email Newsletter:
Be the first to comment
More stories about 21 CFR 11   preclinical   Clinical Evaluation   WuXi AppTec  

Comments

Post new comment

The content of this field is kept private and will not be shown publicly.

More information about formatting options

CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.